We are Developing and Moving Forward•••

  • January 2022

    Signed contracts for and carried out CDMO projects, with many projects under discussion

  • December 2021

    Completed utility systems, production qualification and engineering runs for protein production in Taicang facilities; The team members in BioInno exceeded 100 employees

  • November 2021

    Completed round A financing; Hangzhou Tailong Capital and China Industrial International Trust Limited jointly led the investment; production capacity of Taicang facilities greatly increased

  • May 2021

    Equipment for Taicang facilities arrived at the site

  • February 2021

    Completed the Pre-A round of financing; Tigermed and TigerYear Capital led investment

  • October 2020

    Installation of Taicang facilities started; Suzhou R&D laboratory construction started

  • July 2020

    Angel round financing led to the strategic investment of TigerYear Capital (Tigermed Fund)

  • February 2020

    With the support from local government, BioInno settled in Taicang Biomedical Industrial Park, started design for BioInno facilities with 12,000 square meters, and reserved 7 hectares industrial land for future development.

  • November 2019

    BioInno Bioscience was founded